Multitarget therapy of malignant cancers by the head-to-tail tandem array multiple shRNAs expression system

Area of Science:

• Molecular Biology
• Gene Silencing
• Cancer Research

Background:

• Simultaneous inhibition of multiple genes using coexpressed short hairpin RNAs (shRNAs) is valuable for dissecting complex pathways and cancer therapy.
• Existing methods require efficient and versatile expression systems for targeting multiple genes.

Purpose of the Study:

• To establish a simple and efficient multiple shRNA expression system for simultaneous gene inhibition.
• To evaluate the efficacy of this system in inhibiting key genes involved in cell proliferation and survival.
• To assess the therapeutic potential of the multitarget shRNA system in human prostate cancer cells.

Main Methods:

• Construction of head-to-tail tandem array multiple shRNA expression vectors based on the pSUPER vector.
• Inclusion of six shRNA expression cassettes targeting Bcl-2, Survivin, Akt1, Erk2, CyclinE, and NFkappaB.
• Testing in HeLa and HEK293 cells, followed by evaluation in the human prostate cancer cell line PC3.

Main Results:

• The multiple shRNA constructs efficiently and simultaneously inhibited all six targeted genes in HeLa and HEK293 cells.
• In PC3 prostate cancer cells, the system effectively inhibited all six genes.
• The multitarget shRNA system demonstrated significantly enhanced apoptosis induction in PC3 cells.

Conclusions:

• The developed multiple shRNA expression system is simple, efficient, and capable of simultaneous gene inhibition.
• This multitarget shRNA strategy shows significant potential as an effective approach for cancer therapy.
• The system is adaptable for use with other DNA vector-based shRNA expression systems.